Table 2.
Scale | All PD (n = 333) | TD (n = 50) | PIGD (n = 103) | MIX (n = 180) | p (TD vs. PIGD) | p (PIGD vs. MIX) | p (TD vs. MIX) |
---|---|---|---|---|---|---|---|
Sex (male/female) | 192/141 | 20/30 | 64/39 | 108/72 | 0.015 | 0.800 | 0.015 |
Age | 60.37 ± 10.35 | 62.54 ± 11.06 | 59.48 ± 10.63 | 60.13 ± 10.73 | 0.099 | 0.627 | 0.162 |
Age at onset | 55.28 ± 11.78 | 58.13 ± 11.20 | 54.88 ± 11.34 | 53.69 ± 14.36 | 0.149 | 0.461 | 0.034 |
Disease duration, y | 5.03 ± 4.48 | 4.42 ± 3.91 | 4.60 ± 3.24 | 5.06 ± 4.68 | 0.798 | 0.369 | 0.332 |
LEDD, mg/day | 367.74 ± 382.04 | 318.03 ± 374.02 | 397.64 ± 373.56 | 371.85 ± 388.92 | 0.369 | 0.970 | 0.356 |
H and Y stage | 2 (2, 3) | 2 (2, 3) | 2 (2, 3) | 2 (1, 3) | 0.833 | 0.628 | 0.339 |
pS-α-syn-RBC levels | 2.31 ± 0.70 | 2.19 ± 0.43 | 2.68 ± 1.11 | 2.21 ± 0.51 | 0.001 | <0.001 | 0.855 |
(raw data, μg/ml) | |||||||
pS-α-syn-RBC levels | 14.17 ± 3.58 | 13.05 ± 2.64 | 14.90 ± 5.79 | 14.56 ± 4.77 | 0.029 | 0.573 | 0.055 |
(normalized, μg/mg) | |||||||
pS-α-syn-RBC levels in patients stratified by age at ONSET, ng/mga | |||||||
<50 | 14.06 ± 4.82 | 11.47 ± 1.75 | 14.25 ± 5.75 | 14.40 ± 4.49 | 0.021 | 0.888 | 0.017 |
≥50 | 14.57 ± 4.92 | 12.18 ± 2.45 | 14.89 ± 5.79 | 14.56 ± 4.77 | 0.101 | 0.551 | 0.191 |
50–59 | 14.75 ± 5.44 | 12.33 ± 2.48 | 16.48 ± 7.07 | 14.14 ± 4.84 | 0.087 | 0.073 | 0.669 |
60–69 | 14.70 ± 4.53 | 12.21 ± 2.81 | 13.68 ± 3.75 | 15.60 ± 5.07 | 0.894 | 0.104 | 0.149 |
≥70 | 13.65 ± 4.21 | 11.76 ± 1.55 | 15.07 ± 5.56 | 12.99 ± 3.89 | 0.311 | 0.181 | 0.959 |
pS-α-syn-RBC levels in patients stratified by disease duration, ng/mgb | |||||||
0–2 | 13.11 ± 4.21 | 12.61 ± 2.72 | 13.74 ± 4.58 | 12.73 ± 4.44 | 0.588 | 0.557 | 0.929 |
3–5 | 13.10 ± 4.37 | 11.92 ± 2.38 | 13.91 ± 5.51 | 13.06 ± 3.95 | 0.176 | 0.380 | 0.431 |
5–10 | 13.68 ± 5.03 | 11.06 ± 0.96 | 13.48 ± 5.83 | 14.57 ± 4.88 | 0.411 | 0.259 | 0.092 |
>10 | 15.58 ± 4.97 | 12.30 ± 2.46 | 17.42 ± 6.68 | 15.68 ± 4.54 | 0.146 | 0.120 | 0.637 |
pS-α-syn-RBC levels in patients stratified by HandY STAGES, ng/mgc | |||||||
1 | 11.44 ± 3.36 | 10.90 ± 0.92 | 10.96 ± 3.27 | 11.84 ± 3.88 | 0.858 | 0.647 | 0.551 |
2 | 13.16 ± 4.03 | 12.01 ± 2.33 | 12.97 ± 4.39 | 13.81 ± 4.19 | 0.508 | 0.284 | 0.126 |
3 | 14.09 ± 4.95 | 12.56 ± 2.76 | 15.01 ± 5.73 | 14.01 ± 4.86 | 0.091 | 0.319 | 0.256 |
4–5 | 16.40 ± 6.76 | 12.21 ± 2.81 | 20.87 ± 7.84 | 15.39 ± 5.25 | 0.106 | 0.050 | 0.307 |
Covariance analysis adjusting for sex, age, LEDD and disease duration; Bold: p < 0.05. YOPD, Young onset Parkinson's disease; LOPD, Late onset Parkinson's disease; TD, Tremor-dominant subtype; PIGD, postural instability and gait difficulty subtype.